Skip to main contentSkip to footer content

Research

Study Seeks to Improve Pediatric Patient Safety by Addressing Language Barriers

To help address communication hurdles, the Patient-Centered Outcomes Research Institute (PCORI) has awarded a $438,756 subcontract to Tetyana L. Vasylyeva, M.D., Ph.D., from the TTUHSC School of Medicine.

Patent Issued to TTUHSC Researchers for Potential Early Detectable Blood-Based Biomarker for Alzheimer’s Disease

A US patent was recently awarded to P. Hemachandra Reddy, Ph.D., and Subodh Kumar, Ph.D., from the TTUHSC School of Medicine, focusing on the development of a biomarker for the early detection of Alzheimer’s disease.

TTUHSC’s Guindon Earns International Award for Cannabinoid Research

Josee Guindon, DVM, Ph.D., has been named the 2023 William A Devane Young Investigator Award honoree by the International Cannabinoid Research Society (ICRS).

TTUHSC, TTU Study Published in Genome Biology

Daniel M. Hardy, Ph.D., faculty member in the Department of Cell Biology and Biochemistry at TTUHSC, published a study in biomedical journal Genome Biology.

Diversity, Equity and Inclusion Research Grants Fund Eight New TTUHSC Initiatives

Eight teams within the TTUHSC community were chosen as recipients of research grants offered through the Office of DEI, in collaboration with the Office of Research and the Office of the Provost.

Kang Receives CPRIT Funding to Support West Texas Pharmacology Core

CPRIT recently awarded a five-year, $3.37 million grant to Min Kang, Pharm.D. The grant will support the West Texas Pharmacology Core laboratory at TTUHSC.

Collaborative Analysis Finds No Link Between COVID-19 Vaccines, Guillain Barre Syndrome

The collaborative team's study, “No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study,” was published in August 2022 by the journal Vaccine.

TTUHSC Event Seeks to Spread the Word About Alzheimer’s Disease

The GIA is partnering with the TTUHSC Center of Excellence for Translational Neuroscience and Therapeutics and the School of Medicine’s Department of Pharmacology and Neuroscience to host the Alzheimer’s Awareness Fair 2022.

Study Shows Shaker Channel Mutation Differs Structurally from Human Potassium Channels

In a study led by Luis Cuello, Ph.D., and Alain J. Labro, Ph.D., the researchers investigated whether or not a known mutation (W434F) found within Shaker-IR channel functionally accelerates the C-type inactivation state.

Startups Begin Here! Four Startups Awarded $50,000 from TTUHSC President

The Innovation Hub at Research Park today (September 26, 2022) announced the winners of its annual Presidents' Innovative Startup Awards. The award recognizes startups that have a high potential for growth and an economic impact in West Texas.

New Study Explains Mechanisms of Salt Transport and Could Help Treat Cystic Fibrosis

Pablo Artigas, Ph.D., from TTHSC's School of Medicine’s Department of Cell Physiology and Molecular Biophysics, published a study with his team of collaborators in Nature Communications.

TTUHSC Researchers Receive Second Patent for Specimen Collection Cup

Samuel Prien, Ph.D., and Lindsay Penrose, Ph.D., from the Department of Obstetrics and Gynecology have recently yielded a patent to help address these male-related issues and raise the rate of successful pregnancies.

TTUHSC Scientist Awarded U.S. Patent to Battle Antibiotic Resistance Using Novel Nanoantibiotics

Hongjun Liang, Ph.D., said infection poses a significant challenge for both frontline doctors and scientists alike. It’s a challenge he wants to be able to fight by using innovation to develop a new generation of antibiotics.

Research Identifies, Exploits Vulnerability in Certain High-Risk Cancers

In a study recently published in Cancer Research, a team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director for the TTUHSC School of Medicine Cancer Center, sought to expand upon his lab’s previous research.

TTUHSC Excels in National NSF Innovation Corps Teams

With a regional I-Corps Innovation Hub just down the street from TTUHSC's Lubbock campus, there are continuous opportunities for participation from students and faculty within the Texas Tech University System.

Teaching an Old Drug New Tricks

Sanjay Srivastava, Ph.D., earned a U.S. patent for repurposing an antipsychotic drug to treat various types of cancer.

Humanitarian Effort to Eradicate Schistosomiasis Enters Important Stage

Primarily found in sub-Saharan Africa, the Middle East, Southeast Asia and the Caribbean, schistosomiasis is second only to malaria as a deadly tropical parasitic disease.

Uterine Cancer On the Rise Highlighting Drastic Disparities Among Black and Hispanic/LatinX Women

Cancer experts are ringing alarm bells due to the rise in uterine cancer. Numbers of uterine cancer annually are now equal to ovarian cancer.

Snail Fever Vaccine Reaches First Human Clinical Trial

A preventative vaccine for major tropical disease schistosomiasis has reached a Phase 1 clinical trial, providing a dose for the first healthy human volunteer.

Gene Sequencing an Important Tool in COVID-19 Battle

Gene sequencing, a process of determining the sequential order of the building blocks that make up a strand of DNA, is used to keep pace with the constantly moving target that is COVID-19.

Tags